Cargando…

A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia

Hyperuricemia is a common disease caused by a high level of uric acid. Urate transporter 1 (URAT1) is an important protein and mediates approximately 90% of uric acid reabsorption. Therefore, the URAT1 inhibitor is a class of uricosuric medicines widely used in the clinic for the treatment of hyperu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Qianghua, Cheng, Yuan, Sheng, Rong, Yuan, Yan, Hu, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635963/
https://www.ncbi.nlm.nih.gov/pubmed/36337587
http://dx.doi.org/10.1155/2022/5419890
_version_ 1784824831999475712
author Yuan, Qianghua
Cheng, Yuan
Sheng, Rong
Yuan, Yan
Hu, Mei
author_facet Yuan, Qianghua
Cheng, Yuan
Sheng, Rong
Yuan, Yan
Hu, Mei
author_sort Yuan, Qianghua
collection PubMed
description Hyperuricemia is a common disease caused by a high level of uric acid. Urate transporter 1 (URAT1) is an important protein and mediates approximately 90% of uric acid reabsorption. Therefore, the URAT1 inhibitor is a class of uricosuric medicines widely used in the clinic for the treatment of hyperuricemia. To find the new medicine with stronger URAT1 inhibition and lower toxicity, researchers have been exploring natural products. This study systematically summarizes the natural products with URAT1 inhibition. The results show that many natural products are potential URAT1 inhibitors, such as flavonoids, terpenoids, alkaloids, coumarins, stilbenes, and steroids, among which flavonoids are the most promising source of URAT1 inhibitors. It is worth noting that most studies have focused on finding natural products with inhibition of URAT1 and have not explored their activities and mechanisms toward URAT1. By reviewing the few existing studies of the structure-activity relationship and analyzing common features of natural products with URAT1 inhibition, we speculate that the rigid ring structure and negative charge may be the keys for natural products to produce URAT1 inhibition. In conclusion, natural products are potential URAT1 inhibitors, and exploring the mechanism of action and structure-activity relationship will be an important research direction in the future.
format Online
Article
Text
id pubmed-9635963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-96359632022-11-05 A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia Yuan, Qianghua Cheng, Yuan Sheng, Rong Yuan, Yan Hu, Mei Evid Based Complement Alternat Med Review Article Hyperuricemia is a common disease caused by a high level of uric acid. Urate transporter 1 (URAT1) is an important protein and mediates approximately 90% of uric acid reabsorption. Therefore, the URAT1 inhibitor is a class of uricosuric medicines widely used in the clinic for the treatment of hyperuricemia. To find the new medicine with stronger URAT1 inhibition and lower toxicity, researchers have been exploring natural products. This study systematically summarizes the natural products with URAT1 inhibition. The results show that many natural products are potential URAT1 inhibitors, such as flavonoids, terpenoids, alkaloids, coumarins, stilbenes, and steroids, among which flavonoids are the most promising source of URAT1 inhibitors. It is worth noting that most studies have focused on finding natural products with inhibition of URAT1 and have not explored their activities and mechanisms toward URAT1. By reviewing the few existing studies of the structure-activity relationship and analyzing common features of natural products with URAT1 inhibition, we speculate that the rigid ring structure and negative charge may be the keys for natural products to produce URAT1 inhibition. In conclusion, natural products are potential URAT1 inhibitors, and exploring the mechanism of action and structure-activity relationship will be an important research direction in the future. Hindawi 2022-10-28 /pmc/articles/PMC9635963/ /pubmed/36337587 http://dx.doi.org/10.1155/2022/5419890 Text en Copyright © 2022 Qianghua Yuan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Yuan, Qianghua
Cheng, Yuan
Sheng, Rong
Yuan, Yan
Hu, Mei
A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
title A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
title_full A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
title_fullStr A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
title_full_unstemmed A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
title_short A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
title_sort brief review of natural products with urate transporter 1 inhibition for the treatment of hyperuricemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635963/
https://www.ncbi.nlm.nih.gov/pubmed/36337587
http://dx.doi.org/10.1155/2022/5419890
work_keys_str_mv AT yuanqianghua abriefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT chengyuan abriefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT shengrong abriefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT yuanyan abriefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT humei abriefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT yuanqianghua briefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT chengyuan briefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT shengrong briefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT yuanyan briefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia
AT humei briefreviewofnaturalproductswithuratetransporter1inhibitionforthetreatmentofhyperuricemia